Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01099696 · ClinicalTrials.gov registry record · NA

Study to Evaluate a Probiotic in Healthy Subjects With a History of Abdominal Discomfort and Bloating

A NA study of Bloating and Abdominal Discomfort, sponsored by Procter and Gamble.

Completed
Registry status
NA
Development phase
302
Enrollment target
10
Study locations

NCT01099696 is a NA study of Bloating and Abdominal Discomfort that has completed, run by Procter and Gamble. The registered enrollment target is 302 participants, above the 43-participant average among 5 other Bloating trials with a reported enrollment target (602% higher). The trial reports 10 study locations across 8 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01099696, a NA study of Bloating and Abdominal Discomfort, has completed, sponsored by Procter and Gamble.

COMPLETED
Registry status
NA
Development phase
302 participants
Enrollment target
10
Study locations

Study Summary

This is a multicenter, double-blind, randomized, placebo-controlled, 6-week study of a probiotic for abdominal discomfort and bloating in healthy subjects.

Interventions

  • DIETARY_SUPPLEMENT placebo
  • DIETARY_SUPPLEMENT B. infantis 35624

Study Locations (10)

Illinois

  • Research Site - Chicago
  • Research Site - Rockford

North Carolina

  • Research Site - Chapel Hill
  • Research Site - Greensboro

Indiana

  • Research Site - Indianapolis

Maryland

  • Research Site - Chevy Chase

Ohio

  • Research Site - Cincinnati

South Carolina

  • Research Site - Greer

Tennessee

  • Research Site - Nashville

Virginia

  • Research Site - Charlottesville

Trial Details

FieldValue
Enrollment Target 302 participants
Start Date 2010-04
Est. Completion 2010-10
Phase NA

Sponsor

Procter and Gamble

70 total trials

What the Registry Record Tells You About NCT01099696

The ClinicalTrials.gov registry entry for NCT01099696 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 302 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 43-participant average among 5 other Bloating trials with a reported enrollment target (602% higher). The listed sponsor is Procter and Gamble, which has 70 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Bloating appearing as the primary indexed condition, and to 2 interventions - of which placebo is the first listed.

NCT01099696 reports 10 study locations spanning 8 distinct geographic areas - top geographies include Illinois, North Carolina, Indiana.

Frequently Asked Questions

What is clinical trial NCT01099696 about?

NCT01099696 is a clinical study titled "Study to Evaluate a Probiotic in Healthy Subjects With a History of Abdominal Discomfort and Bloating". This is a multicenter, double-blind, randomized, placebo-controlled, 6-week study of a probiotic for abdominal discomfort and bloating in healthy subjects.

What is the current status of trial NCT01099696?

This trial is currently completed. It is a NA study. The enrollment target is 302 participants. The study started on 2010-04. Estimated completion is 2010-10.

What conditions does trial NCT01099696 study?

This clinical trial studies the following conditions: Bloating, Abdominal Discomfort.

What interventions are being tested in trial NCT01099696?

The interventions under investigation include: placebo (DIETARY_SUPPLEMENT), B. infantis 35624 (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT01099696?

This trial is sponsored by Procter and Gamble, which has 70 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01099696 being conducted?

This trial has 10 study locations across Illinois, Indiana, Maryland, North Carolina, Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Bloating

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.